Bioscience Managers Pty Ltd (formerly IB Managers) is a leading life sciences investment firm, headquartered in Melbourne, Australia. Established in 2003, Bioscience Managers offers a global, multi-disciplinary team, bringing an international perspective together with the track record, networks and expertise required to convert that perspective into informed, high return investment decisions.
We operate a high value-add model, providing assistance and support to portfolio companies via our global team and international network of independent industry advisors. With combined experience of over 170 investments, more than 40 IPO’s/ reversals in Europe, the USA and Australia, and a diverse skillset specific to the bio-based industries, we aim to provide investee companies with significant value-add over and above capital invested.
Alongside our funds management business, Phillip Bioscience Advisory provides specialist corporate advisory services to healthcare and life sciences companies.
Bioscience Managers is a part of the PhillipCapital group http://phillipcapital.com.au
We operate a high value-add model, providing assistance and support to portfolio companies via our global team and international network of independent industry advisors. With combined experience of over 170 investments, more than 40 IPO’s/ reversals in Europe, the USA and Australia, and a diverse skillset specific to the bio-based industries, we aim to provide investee companies with significant value-add over and above capital invested.
Alongside our funds management business, Phillip Bioscience Advisory provides specialist corporate advisory services to healthcare and life sciences companies.
Bioscience Managers is a part of the PhillipCapital group http://phillipcapital.com.au
Location: Australia, Victoria, Melbourne
Employees: 11-50
Founded date: 2003
Investment Type: Venture Capital
Portfolio 24
| Date | Name | Website | Total Raised | Location |
| 22.09.2021 | humanetix | humanetix.com.au | - | Australia,... |
| 11.12.2020 | Cynata The... | cynata.com | $15M | Australia,... |
| - | Adaptix Lt... | adaptiximaging.com | - | United Kin... |
| - | Acrux | acrux.com.au | $7.8M | Australia,... |
| - | Pharmamark | pharmamark.com.au | - | - |
| - | The Electr... | electrospinning.co.uk | $8.73M | United Kin... |
| - | Fundamenta... | fundamentalvr.com | $27.07M | United Sta... |
| - | CalciMedic... | calcimedica.com | $36M | United Sta... |
| - | Open Bioni... | openbionics.com | $5.9M | Jamaica |
| - | GKC | globalkineticscorporation.com.au | $1.5M | - |
Show more
Persons 12
| Date | First Name | Last Name | Title | Location | |||
| - | Victoria | Durrans | Partner | linkedin.c... | - | - | - |
| - | Bruce | McHarrie | Senior Par... | linkedin.c... | - | - | - |
| - | Nicole | Vitullo | Independen... | linkedin.c... | - | - | - |
| - | Dr. | Amanda Gil... | Senior Par... | linkedin.c... | - | - | - |
| - | Dr. | Simon Gree... | Venture Pa... | linkedin.c... | - | - | - |
| - | Jeremy | Curnock Co... | Managing P... | linkedin.c... | - | - | - |
| - | Dr. | Işıl Güney... | Senior Par... | linkedin.c... | - | - | - |
| - | Dr. | Geoff Broo... | Senior Par... | linkedin.c... | - | - | - |
| - | Dr. | Mike Perry | Venture Pa... | linkedin.c... | - | - | - |
| - | Dr. | Graham Cro... | Venture Pa... | - | - | - |
Show more
Mentions in press and media 5
| Date | Title | Description |
| 03.05.2023 | Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO | CHARLOTTE, N.C. and MELBOURNE, Australia, May 3, 2023 /PRNewswire/ -- Global Kinetics, the global leader in digital health solutions for neurological conditions, today announced the appointment of Zach Henderson as its new Chief Executive O... |
| 11.12.2020 | Cynata Therapeutics : Secures $15m Placement Led By $10m from Healthcare Investor BioScience Managers to Expand Development Pipeline | MELBOURNE, Australia, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce a successful $15 ... |
| 11.12.2020 | CYNATA THERAPEUTICS LIMITED Cynata Therapeutics : Secures $15m Placement Led By $10m from Healthcare Investor BioScience Managers to Expand Development Pipeline | MELBOURNE, Australia, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce a successful $15 ... |
| 24.10.2008 | Phenomix cancels IPO, finds new lab partner | Biopharmaceuticals company Phenomix withdrew its filing to go public yesterday and right away announced a $340-million collaboration deal with Forest Laboratories. The IPO, intended to raise $86.3 million, had been pending since January. Fo... |
| - | Downing FOUR VCT Healthcare Share Class open for tax year-end investments | As the tax year draws to a close, the Downing FOUR Venture Capital Trust (VCT) Healthcare Share Class remains open for end of tax year investments as part of a £10.2m top-up offer. The VCT, which is managed by investment manager Downing LL... |